RFK Jr. promotes peptides. Now the FDA weighs easing limits on the unproven chemicals An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica Peptides Lack Reliable Safety Information, Watchdog Warns FDA moves toward easing restrictions on certain peptides BioPharma Dive FDA Compliance for Peptide Therapy and BPC 157 Holt Law The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York